[HTML][HTML] Tumor hypoxia as a barrier in cancer therapy: why levels matter

T Hompland, CS Fjeldbo, H Lyng - Cancers, 2021 - mdpi.com
Simple Summary Hypoxia is a common feature of solid tumors and associated with poor
outcome in most cancer types and treatment modalities, including radiotherapy …

[HTML][HTML] Tumor response assessment on imaging following immunotherapy

AM Berz, C Dromain, N Vietti-Violi, S Boughdad… - Frontiers in …, 2022 - frontiersin.org
In recent years, various systemic immunotherapies have been developed for cancer
treatment, such as monoclonal antibodies (mABs) directed against immune checkpoints …

[HTML][HTML] Th17. 1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma

AM Leipold, RA Werner, J Düll, P Jung, M John… - Leukemia, 2023 - nature.com
Pseudo-progression and flare-up phenomena constitute a novel diagnostic challenge in the
follow-up of patients treated with immune-oncology drugs. We present a case study on …

Pilot study of a novel nanobody 68 Ga-NODAGA-SNA006 for instant PET imaging of CD8+ T cells

Y Wang, C Wang, M Huang, S Qin, J Zhao… - European Journal of …, 2022 - Springer
Purpose Positron emission tomography (PET) with specific diagnostic probes for quantifying
CD8+ T cells has emerged as a powerful technique for monitoring the immune response …

[HTML][HTML] Immuno-imaging (PET/SPECT)–quo vadis?

CS Kramer, A Dimitrakopoulou-Strauss - Molecules, 2022 - mdpi.com
The use of immunotherapy has revolutionized the treatment regimen of certain cancer types,
but response assessment has become a difficult task with conventional methods such as …

[HTML][HTML] Preclinical Evaluation of 89Zr-Df-IAB22M2C PET as an Imaging Biomarker for the Development of the GUCY2C-CD3 Bispecific PF-07062119 as a T Cell …

KP Maresca, J Chen, D Mathur… - Molecular Imaging and …, 2021 - Springer
Purpose A sensitive and specific imaging biomarker to monitor immune activation and
quantify pharmacodynamic responses would be useful for development of …

[PDF][PDF] 正电子显像技术在肿瘤免疫治疗个体化用药中的研究进展

王燕, 边诣聪, 缪丽燕 - PROGRESS IN PHARMACEUTICAL …, 2021 - pps.cpu.edu.cn
肿瘤免疫治疗是近年来肿瘤治疗领域的重大突破, 在多种恶性肿瘤中展示出显著的抗肿瘤效果.
然而, 临床使用提示不同患者对肿瘤免疫治疗的反应存在明显的个体差异, 如何进行个体化治疗 …